Sponsored by:

Nuclear Medicine: Page 165

Sofie Biosciences receives NIH grant
By AuntMinnie.com staff writers
Molecular imaging developer Sofie Biosciences has received a grant of approximately $1.8 million from the U.S. National Institutes of Health (NIH).
October 1, 2013
Positron signs deal with Russian academy
By AuntMinnie.com staff writers
PET vendor Positron has signed a licensing agreement with the Institute for Nuclear Research of the Russian Academy of Science in Moscow.
September 30, 2013
Lilly 'disappointed' with CMS beta-amyloid PET decision
By AuntMinnie.com staff writers
Once again, drug developer Eli Lilly is expressing disappointment with a regulatory decision related to its Amyvid PET radiopharmaceutical for the detection of Alzheimer's disease.
September 30, 2013
MITA lukewarm on CMS' PET decision
By AuntMinnie.com staff writers
The Medical Imaging and Technology Alliance (MITA) cited progress in the U.S. Centers for Medicare and Medicaid Services' (CMS) final decision on beta-amyloid PET coverage; however, the organization said it was disappointed by the scope.
September 30, 2013
ICER: Evidence of beta-amyloid PET's efficacy still lacking
By Wayne Forrest
A review of clinical studies on the efficacy of beta-amyloid PET for Alzheimer's disease has led the Institute for Clinical and Economic Review (ICER) to conclude that evidence supporting the scans is still lacking, according to an article published online September 30 in JAMA Internal Medicine.
September 30, 2013
CMS upholds PET decision for dementia
By AuntMinnie.com staff writers
The U.S. Centers for Medicare and Medicaid Services (CMS) is holding to its position restricting reimbursement for PET imaging for dementia or neurodegenerative disease.
September 26, 2013
UltraSPECT promotes low-dose protocol study
By AuntMinnie.com staff writers
Nuclear medicine firm UltraSPECT is touting a study that found that the company's imaging protocols meet American Society of Nuclear Cardiology low-dose guidelines.
September 26, 2013
Global radiopharma market poised to expand
By AuntMinnie.com staff writers
The global radiopharmaceuticals market could reach $5.5 billion U.S. (4.1 billion euros) by 2017, growing at a compound annual growth rate of 7.8%.
September 26, 2013
AMIC looks for European investors
By AuntMinnie.com staff writers
Medical isotope producer Advanced Medical Isotope (AMIC) has signed an agreement to try to attract European investors.
September 25, 2013
Zevacor to buy 70-MeV cyclotron
By AuntMinnie.com staff writers
PET and SPECT radiopharmaceutical firm Zevacor Molecular plans to purchase a 70-MeV commercial cyclotron within 30 days.
September 25, 2013
MILabs touts Duke microSPECT study
By AuntMinnie.com staff writers
Preclinical imaging technology developer MILabs is touting a study published online in Molecular Imaging and Biology that concluded 4D microSPECT works for studying murine cardiac function.
September 25, 2013
PET can help with early Alzheimer's diagnosis
By AuntMinnie.com staff writers
FDG-PET can help diagnose Alzheimer's disease sooner than usual and lead to better patient outcomes through the use of disease-specific medication.
September 25, 2013
Previous Page
Page 165 of 440
Next Page